You have 9 free searches left this month | for more free features.

City

Philadelphia (2)

Copenhagen (1)

Manchester (1)

Oslo (1)

St. Petersburg (1)

Condition

Carcinoma, Non-Small-Cell Lung (1)

Non-Small-Cell Lung Carcinoma (1)

Pancreatic Cancer (1)

Renal Cell Carcinoma (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Active Biotech AB (2)

Collaborator

Intervention

abr-217620 (2)

docetaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

abr-217620

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in Philadelphia, Copenhagen, St. Petersburg (ABR-217620, docetaxel)

Completed

Carcinoma, Non-Small-Cell Lung

ABR-217620
docetaxel

Philadelphia, Pennsylvania
+3 more

Aug 26, 2014

Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Pancreatic Cancer Trial in Philadelphia, Oslo, Manchester (ABR-217620)

Completed

Non-Small-Cell Lung Carcinoma
+2 more

ABR-217620

Philadelphia, Pennsylvania
+2 more

Aug 26, 2014